• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传和结构分析揭示了 SARS-CoV-2 EG.5 变体的低潜力。

Genetic and structural analyses reveal the low potential of the SARS-CoV-2 EG.5 variant.

机构信息

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza Università di Roma, Rome, Italy.

出版信息

J Med Virol. 2023 Sep;95(9):e29075. doi: 10.1002/jmv.29075.

DOI:10.1002/jmv.29075
PMID:37665162
Abstract

The severe acute respiratory syndrome coronavirus 2 EG.5 lineage is the latest variant under monitoring, and it is generating significant concern due to its recent upward trend in prevalence. Our aim was to gain insights into this emerging lineage and offer insights into its actual level of threat. Both genetic and structural data indicate that this novel variant presently lacks substantial evidence of having a high capacity for widespread transmission. Their viral population sizes expanded following a very mild curve and peaked several months after the earliest detected sample. Currently, neither the viral population size of EG.5 nor that of its first descendant is increasing. The genetic variability appear to be flattened, as evidenced by its relatively modest evolutionary rate (9.05 × 10 subs/site/year). As has been observed with numerous prior variants, attributes that might theoretically provide advantages seem to stem from genetic drift, enabling the virus to continually adjust to its host, albeit without a clear association with enhanced dangerousness. These findings further underscore the necessity for ongoing genome-based monitoring, ensuring preparedness and a well-documented understanding of the unfolding situation.

摘要

严重急性呼吸系统综合征冠状病毒 2 型 EG.5 谱系是最新的监测变种,由于其近期流行率呈上升趋势,引起了极大关注。我们的目的是深入了解这一新兴谱系,并深入了解其实际威胁程度。遗传和结构数据均表明,这种新型变体目前没有大量证据表明其具有广泛传播的高能力。它们的病毒种群规模在一条非常温和的曲线上扩张,并在最早检测到的样本几个月后达到峰值。目前,EG.5 的病毒种群规模及其第一个后代的病毒种群规模均未增加。遗传变异性似乎趋于平稳,其进化率相对较低(9.05×10 个替代位/年)。与之前的许多变体一样,理论上可能具有优势的属性似乎源于遗传漂变,使病毒能够不断适应其宿主,尽管与危险性增加没有明显关联。这些发现进一步强调了基于基因组的持续监测的必要性,以确保做好准备,并对不断发展的情况有充分记录的了解。

相似文献

1
Genetic and structural analyses reveal the low potential of the SARS-CoV-2 EG.5 variant.遗传和结构分析揭示了 SARS-CoV-2 EG.5 变体的低潜力。
J Med Virol. 2023 Sep;95(9):e29075. doi: 10.1002/jmv.29075.
2
Genome-based survey of the SARS-CoV-2 BF.7 variant from Asia.基于基因组的亚洲新冠病毒BF.7变异株调查。
J Med Virol. 2023 Apr;95(4):e28714. doi: 10.1002/jmv.28714.
3
Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant.基于整合基因组的 SARS-CoV-2 奥密克戎 XBB.1.16 变体调查。
Int J Mol Sci. 2023 Sep 1;24(17):13573. doi: 10.3390/ijms241713573.
4
Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.SARS-CoV-2 基因变异的进化追踪突显了稳定和不稳定突变之间的复杂平衡。
mBio. 2021 Aug 31;12(4):e0118821. doi: 10.1128/mBio.01188-21. Epub 2021 Jul 20.
5
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.两种 SARS-CoV-2 欧洲谱系 20E 刺突突变的进化和表型特征。
mBio. 2021 Dec 21;12(6):e0231521. doi: 10.1128/mBio.02315-21. Epub 2021 Nov 16.
6
Evidence of increasing diversification of emerging Severe Acute Respiratory Syndrome Coronavirus 2 strains.新兴严重急性呼吸综合征冠状病毒 2 株系多样化证据增加。
J Med Virol. 2020 Oct;92(10):2165-2172. doi: 10.1002/jmv.26018. Epub 2020 Aug 2.
7
Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.两步策略测序揭示突尼斯高传播期后 SARS-CoV-2 S 基因的高遗传多样性。
Microbiol Spectr. 2021 Dec 22;9(3):e0063921. doi: 10.1128/Spectrum.00639-21. Epub 2021 Nov 10.
8
Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2.严重急性呼吸综合征冠状病毒 2 这一国际关注的新兴威胁的流行历史和演变。
J Med Virol. 2023 Aug;95(8):e29012. doi: 10.1002/jmv.29012.
9
Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.SARS-CoV-2 和其他冠状病毒基因组中猖獗的 C→U 超突变:对其短期和长期进化轨迹的原因和后果。
mSphere. 2020 Jun 24;5(3):e00408-20. doi: 10.1128/mSphere.00408-20.
10
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.西班牙的 SARS-CoV-2 早期传播归因于创始效应。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01583-20.

引用本文的文献

1
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies.SARS-CoV-2 奥密克戎:病毒进化、免疫逃逸和替代持久治疗策略。
Viruses. 2024 Apr 28;16(5):697. doi: 10.3390/v16050697.
2
Comprehensive Analysis of Omicron Subvariants: EG.5 Rise, Vaccination Strategies, and Global Impact.奥密克戎亚型的综合分析:例如,EG.5 崛起、疫苗接种策略和全球影响。
Curr Drug Targets. 2024;25(8):517-525. doi: 10.2174/0113894501296586240430061915.
3
On the SARS-CoV-2 Variants.关于严重急性呼吸综合征冠状病毒2变体
Infect Dis Rep. 2024 Mar 26;16(2):289-297. doi: 10.3390/idr16020024.
4
Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion.SARS-CoV-2 刺突受体结合域的突变及其在与 ACE2 亲和力和抗体逃逸之间的微妙平衡。
Protein Cell. 2024 May 28;15(6):403-418. doi: 10.1093/procel/pwae007.
5
Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 Trial.四价蛋白疫苗SCTV01E-2针对SARS-CoV-2 EG.5亚变体的免疫原性:一项2期试验。
Vaccines (Basel). 2024 Feb 8;12(2):175. doi: 10.3390/vaccines12020175.
6
EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19.EG.5(Eris)和 BA.2.86(Pirola):两种新的 SARS-CoV-2 亚变体:旧 COVID-19 的新面貌。
Infection. 2024 Apr;52(2):337-343. doi: 10.1007/s15010-023-02146-0. Epub 2024 Jan 3.
7
COVID-19: On the threshold of the fifth year. The situation in Spain.新冠疫情:步入第五年。西班牙的情况。
Rev Esp Quimioter. 2024 Feb;37(1):17-28. doi: 10.37201/req/123.2023. Epub 2023 Nov 27.